Le Lézard
Classified in: Health
Subjects: PDT, FDA

Interventional Systems receives FDA clearance for its all-around miniature medical robot


KITZBÜHEL, Austria, June 29, 2021 /PRNewswire/ -- Interventional Systems announced MicromateTM, the world's smallest robot for percutaneous procedures, received its FDA 510(k) clearance, allowing the robotics company to operate in the USA.

MicromateTM is a table-mounted medical robot for interventional procedures with a universal instrument guidance solution that allows physicians to continue using their preferred surgical instruments. Targeting is performed under live-imaging using any Cone-Beam Computerized Tomography (CT), Fluoro CT or a Fluoroscope.

"We appreciate the partnership developed with the FDA to rigorously validate safety and accuracy. It is not trivial to develop a full-fledged robotic platform that puts surgeons in charge of so many different procedures with the same core technology, while ensuring a seamless integration into the clinical workflow", states Pedro Costa, Interventional Systems CPO.

"After a successful start with our partners in Europe and over ten years of experience in medical robotics, we decided it was about time we reached the other side of the pond", states Michael Vogele, Interventional Systems' founder and CEO.  "We are sure our product is bound to democratize medical robotics in the US. The proven submillimeter accuracy and affordable price make it the most seasoned choice for any institution that is looking for new technology in order to improve the outcomes of interventional procedures", he adds.

The company plans to launch operations in the USA throughout the second-half of 2021 by launching centers of excellence for robotic-guided interventional procedures and establishing commercial partnerships with third-parties that look for a  robotic offering to their customers.

About Interventional Systems: Interventional Systems/iSYS (www.interventional-systems.com) is the precision medical robotics company for the 21st century.

Through its miniature robotics solutions for image guided interventions and patient stabilization products, Interventional Systems leverages technology to bring medical interventions into the future. Interventional Systems is committed to making healthcare simpler, more comfortable, more hygienic, more affordable, and more efficient.

Interventional Systems is headquartered in Kitzbühel, Austria, and has offices in Austria and Germany.

Contact person:
Vanessa Costa
Marketing Manager
(+351) 914 014 002
vanessa.costa@interventional-systems.com

SOURCE Interventional Systems


These press releases may also interest you

at 16:20
In the Phase 3 VALOR study, the primary endpoint as measured by the Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R) did not reach statistical significance; however, signs of reduced disease progression across multiple...

at 16:20
Ionis Pharmaceuticals, Inc. partner Biogen today announced topline results from its placebo-controlled pivotal Phase 3 VALOR study of tofersen (BIIB067), an investigational antisense medicine being evaluated for people with superoxide dismutase 1...

16 oct 2021
Core One Labs Inc. , , (the "Company") a research and technology company focused in life sciences and on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy, congratulates Seattle's city...

16 oct 2021
Neurocrine Biosciences, Inc.  today announced that it will present key information from its movement disorder treatments for Parkinson's disease and tardive dyskinesia (TD) at the American Neurological Association (ANA) 2021 Virtual Annual Meeting...

16 oct 2021
HLNY's highest recognition, the "Award of Distinction" will be presented to Arthur Gianelli, FACHE, Chief Transformation Officer of Mount Sinai Health System and President of Mount Sinai Morningside. This award recognizes a healthcare executive who...

16 oct 2021
Regulated Information ? Inside Information ? UCB, a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that they were unable to complete review of the Biologics License...



News published on 29 june 2021 at 09:00 and distributed by: